Tag: antibiotic biotech

Biotech, Industry

Innoviva buys struggling antibiotic biotech Entasis, as the AstraZeneca spin out preps FDA filing

May 23, 2022

Via: FierceBiotech

Holding company Innoviva is acquiring late-stage antibiotic biotech Entasis Therapeutics, a 2015 AstraZeneca spin-out that just posted phase 3 results worthy of an FDA filing last year. Innoviva already owns about 60% of Entasis’ outstanding shares. Under the new definitive […]